DermQuest logo

For Healthcare Professionals Only

Editorial Board |  Contact Us |  Sitemap |  Log in |  Register |  Help
 
The art, science and practice of dermatology

Forgotten login details?
Register

The latest from Dermquest

Research Updates

IL-12 and IL-23 and Psoriasis

11 July 2008

Steven R. Feldman, MD, PhD
Inhibitors of IL-12 and IL-23 appear to be very potent treatments for psoriasis. Dr. Steven Feldman believes that if they prove to be very safe, another quantum leap in treatment for patients with severe psoriasis may be achieved.

Clinical Updates

Skin Barrier Therapy and Atopic Dermatitis

20 June 2008

Eric L. Simpson, M.D.
According to Dr. Eric Simpson, the era of skin barrier-targeted therapies for atopic dermatitis is still in its infancy. In this article, Dr. Simpson discusses some of the new products, both prescription and over-the-counter, to emerge in the marketplace.

News Headlines

Poor HRQoL in psoriasis patients improved by infliximab therapy

18 July 2008

Infliximab improves health-related quality of life in patients with moderate-to-severe psoriasis, even those with severe disease, depression, and psoriatic arthritis, say US scientists.

Pimecrolimus enhances NB-UVB benefits in facial vitiligo

18 July 2008

Narrow-band ultraviolet B therapy is more effective in treating vitiligo facial lesions when used in combination with pimecrolimus cream, study findings suggest.

Risk factors for severe acne flare on isotretinoin identified

18 July 2008

Male gender, severe acne, macrocomedones, presence of truncal comedones, a higher number of facial comedones, and the presence of more than two facial nodules are risk factors for severe acne flare during isotretinoin treatment, say researchers in Turkey.